JR

Jerry Rosenblatt

Board Member at Achelios Therapeutics

Dr. Rosenblatt is a Partner at Foster Rosenblatt, an international market research and advisory firm, exclusively focused on life sciences. Dr. Rosenblatt is a former Professor of Marketing, Associate Dean and Director of the MBA and Executive Development Programs at the John Molson School of Business, Concordia University, Montreal. He is a former Professor of Marketing and graduate of McGill University, one of Canada’s leading academic institutions. Dr. Rosenblatt was the Global Practice Leader, Forecasting and Opportunity Assessment practice for IMS Consulting (a leading healthcare research company), with over 25 years of experience as marketing advisor to pharmaceutical companies.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Achelios Therapeutics

Achelios Therapeutics’ lead reformulation product, TOPOFEN™, pairs its proprietary ACHETOGEL™ delivery technology with the proven NSAID ketoprofen. In pre-clinical and early-stage clinical studies, they have shown TOPOFEN™ (ketoprofen) to provide superior tissue penetration compared to other topical formulations currently on the market.


Industries

Employees

1-10

Links